FMSM Board President Ken Brazerol said it’s “especially important to have a pioneer in the scientific community in the area backing this project. That, I think, is just really, really cool.”
Word of the donation was announced last week following an anonymous donation of $225,000, but Ballantyne’s name wasn’t released then.
In a statement, Ballantyne, who started Aldevron with Michael Chambers on the campus of NDSU in 1998, said “as cliche as it sounds I still feel people don’t have an appreciation for just how much scientific development has gone into virtually everything they touch, eat or interact with on a daily basis.
“The concept of the museum and what it means for the area is long overdue and just based on a relatively brief conversation with the board, I know the group has what it takes to make this a reality,” Ballantyne said.
The board has also hired JLG Architects of Fargo to help them identify what’s needed in a building. For example, he said they will likely need a loading dock for huge trucks for exhibits. All three cities in the metro are being considered as possible sites for the museum.
Brazerol said they are using some of the initial funding to hire an executive director for the museum. He said the search is expected to start early next month with the position filled likely by late spring.
As that work continues, Brazerol said they are also planning to use early funds for a traveling Science, Technology, Engineering and Mathematics (STEM) van to reach out to the community and children as an initial step towards building a permanent museum.
The museum hopes to offer STEM learning through interactive exhibits and programming.
Ballantyne received his undergraduate degree in pharmacy in his native New Zealand before moving from the graduate program at the University of Otago to NDSU where he received his doctorate in pharmaceutical sciences. Aldevron, which was sold last year to the Danaher Corp. of Washington, D.C., for $9.6 billion, is a leading global provider of high quality plasmid DNA, mRNA producer and antibody developer. The company, with its 14 acre campus in Fargo, has been a major hub for making a key ingredient for COVID-19 vaccines with its 600 employees.
Check the latest news about Science news section for best information related to science news topic.